VanGuilder M - Search Results

1

Combination treatment with meropenem plus levofloxacin is synergistic against Pseudomonas aeruginosa infection in a murine model of pneumonia.

Louie A, Liu W, VanGuilder M, Neely MN, Schumitzky A, Jelliffe R, Fikes S, Kurhanewicz S, Robbins N, Brown D, Baluya D, Drusano GL. Louie A, et al. Among authors: vanguilder m. J Infect Dis. 2015 Apr 15;211(8):1326-33. doi: 10.1093/infdis/jiu603. Epub 2014 Oct 31. J Infect Dis. 2015. PMID: 25362196 Free PMC article.

2

Analysis of combination drug therapy to develop regimens with shortened duration of treatment for tuberculosis.

Drusano GL, Neely M, Van Guilder M, Schumitzky A, Brown D, Fikes S, Peloquin C, Louie A. Drusano GL, et al. PLoS One. 2014 Jul 8;9(7):e101311. doi: 10.1371/journal.pone.0101311. eCollection 2014. PLoS One. 2014. PMID: 25003557 Free PMC article.

3

Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R.

Neely MN, van Guilder MG, Yamada WM, Schumitzky A, Jelliffe RW. Neely MN, et al. Ther Drug Monit. 2012 Aug;34(4):467-76. doi: 10.1097/FTD.0b013e31825c4ba6. Ther Drug Monit. 2012. PMID: 22722776 Free PMC article.

4

Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance.

Docobo-Pérez F, Drusano GL, Johnson A, Goodwin J, Whalley S, Ramos-Martín V, Ballestero-Tellez M, Rodriguez-Martinez JM, Conejo MC, van Guilder M, Rodríguez-Baño J, Pascual A, Hope WW. Docobo-Pérez F, et al. Antimicrob Agents Chemother. 2015 Sep;59(9):5602-10. doi: 10.1128/AAC.00752-15. Epub 2015 Jun 29. Antimicrob Agents Chemother. 2015. PMID: 26124169 Free PMC article.

5

Population pharmacokinetics/pharmacodynamics modeling: parametric and nonparametric methods.

Jelliffe R, Schumitzky A, Van Guilder M. Jelliffe R, et al. Ther Drug Monit. 2000 Jun;22(3):354-65. doi: 10.1097/00007691-200006000-00019. Ther Drug Monit. 2000. PMID: 10850405

6

A two-compartment population pharmacokinetic-pharmacodynamic model of digoxin in adults, with implications for dosage.

Jelliffe RW, Milman M, Schumitzky A, Bayard D, Van Guilder M. Jelliffe RW, et al. Ther Drug Monit. 2014 Jun;36(3):387-93. doi: 10.1097/FTD.0000000000000023. Ther Drug Monit. 2014. PMID: 24492383 Free PMC article.

7

Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin Dosing.

Neely MN, Kato L, Youn G, Kraler L, Bayard D, van Guilder M, Schumitzky A, Yamada W, Jones B, Minejima E. Neely MN, et al. Antimicrob Agents Chemother. 2018 Jan 25;62(2):e02042-17. doi: 10.1128/AAC.02042-17. Print 2018 Feb. Antimicrob Agents Chemother. 2018. PMID: 29203493 Free PMC article. Clinical Trial.

8

Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy.

Felton TW, Roberts JA, Lodise TP, Van Guilder M, Boselli E, Neely MN, Hope WW. Felton TW, et al. Antimicrob Agents Chemother. 2014 Jul;58(7):4094-102. doi: 10.1128/AAC.02664-14. Epub 2014 May 5. Antimicrob Agents Chemother. 2014. PMID: 24798288 Free PMC article.

9

Achieving target goals most precisely using nonparametric compartmental models and "multiple model" design of dosage regimens.

Jelliffe R, Bayard D, Milman M, Van Guilder M, Schumitzky A. Jelliffe R, et al. Ther Drug Monit. 2000 Jun;22(3):346-53. doi: 10.1097/00007691-200006000-00018. Ther Drug Monit. 2000. PMID: 10850404

10

[No title available]

[No authors listed] [No authors listed] PMID: 32796388

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters